COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
Objectives We aimed to investigate the role of rheumatoid arthritis (RA) with biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) exposure in COVID-19 outcomes.Methods Our study retrieved data from the US Collaborative Network in TriNetX between 1 January 2018 and 31 Dec...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2023-07-01
|
| Serie: | RMD Open |
| Accesso online: | https://rmdopen.bmj.com/content/9/3/e003038.full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|